Researchers at the University of Texas MD Anderson Cancer Center have developed a novel antibody-toxin conjugate (ATC) ...
Clinical studies suggest that the mRNA vaccine may play a role in treating pancreatic cancer, identified as one of the most ...
Cancers occurring in the mouth, nose, and throat are on the rise in the U.S., especially in younger people. About 60,000 new ...
The new joint venture is described as a first-of-its-kind joint venture and was approved by the UT System Board of Regents ...
The initiative will bring over 300 cancer specialists to bear on the issue of pediatric cancer care, according to hospital ...
Dr. Christopher R. Flowers explains that MRD testing varies by cancer type, with results impacting recurrence risk and ...
Using a new technology and computational method, researchers have uncovered a biomarker capable of accurately predicting outcomes in meningioma brain tumors and breast cancers.
The University of Texas MD Anderson Cancer Center and Texas Children’s Hospital are forming a new partnership aimed at ...